日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study

70基因特征指导的早期ER+乳腺癌患者辅助全身治疗方案调整:一项前瞻性多中心队列研究的7年随访

Verreck, Eline E F; Kuijer, Anne; van Steenhoven, Julia E C; Volders, José H; van der Velden, Annette W G; Siesling, Sabine; Timmer-Bonte, Anja N H; Smilde, Tineke J; Imholz, Alex L T; Blanken-Peeters, Charlotte F J M; de Valk, Bart; Vrijaldenhoven, Suzan; Lastdrager, Willem B; Haringhuizen, Annebeth W; Hunting, Jarmo C B; Hovenga, Sjoerd; Nieboer, Peter; Zuetenhorst, Hanneke M; Tetteroo, Geert W M; Smorenburg, Carolien H; van Maaren, Marissa C; van Dalen, Thijs

Fostering the Conversation About Complementary Medicine: Acceptability and Usefulness of Two Communication-Supporting Tools for Patients with Cancer

促进关于辅助医学的对话:两种癌症患者沟通辅助工具的可接受性和实用性

Mentink, Marit; Noordman, Janneke; Timmer-Bonte, Anja; Busch, Martine; van Dulmen, Sandra

The Effects of Complementary Therapies on Patient-Reported Outcomes: An Overview of Recent Systematic Reviews in Oncology

辅助疗法对患者报告结局的影响:肿瘤学近期系统评价概述

Mentink, Marit; Verbeek, Daniëlle; Noordman, Janneke; Timmer-Bonte, Anja; von Rosenstiel, Ines; van Dulmen, Sandra

Perspectives and Attitudes of Dutch Healthcare Professionals Regarding the Integration of Complementary Medicine in Oncology

荷兰医疗保健专业人员对肿瘤学中补充医学整合的看法和态度

Schouten, Aniek E M; Mentink, Marit D C; Timmer-Bonte, Johanna Anja N H; Noordman, Janneke; van Dulmen, Sandra

Towards an open and effective dialogue on complementary medicine in oncology: protocol of patient participatory study 'COMMON'

迈向肿瘤学领域补充医学的公开有效对话:患者参与式研究“COMMON”方案

Mentink, Marit; Noordman, Janneke; Busch, Martine; van Vliet, Liesbeth; Timmer-Bonte, Johanna Anja; van Dulmen, Sandra

Changes in body composition during and after adjuvant or neo-adjuvant chemotherapy in women with breast cancer stage I-IIIB compared with changes over a similar timeframe in women without cancer

与未患乳腺癌的女性在类似时间段内的身体成分变化相比,I-IIIB期乳腺癌女性在辅助或新辅助化疗期间和之后的身体成分变化情况

van den Berg, M M G A; Kok, D E; Visser, M; de Vries, J H M; de Kruif, J Th C M; de Vries, Y; Posthuma, L; Sommeijer, D W; Timmer-Bonte, A; Los, M; van Laarhoven, H W M; Kampman, E; Winkels, Renate M

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy

体成分与接受化疗的I-IIIB期乳腺癌女性患者因化疗毒性而导致治疗方案改变的风险相关。

van den Berg, Maaike M G A; Kok, Dieuwertje E; Posthuma, Liesbeth; Kamps, Lisette; Kelfkens, Celine S; Buist, Nicole; Geenen, Maud; Haringhuizen, Annebeth; Heijns, Joan B; van Lieshout, Rianne H M A; Los, Maartje; Sommeijer, Dirkje W; Timmer-Bonte, Johanna N H; de Kruif, Anja Th C M; van Laarhoven, Hanneke W M; Kampman, Ellen; Winkels, Renate M

Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study

传统病理学与基因特征在评估管腔A型和B型乳腺癌中的应用:一项前瞻性队列研究的结果

van Steenhoven, Julia E C; Kuijer, Anne; van Diest, Paul J; van Gorp, Joost M; Straver, Marieke; Elias, Sjoerd G; Wesseling, Jelle; Rutgers, Emiel; Timmer-Bonte, Johanna N H; Nieboer, Peter; Smilde, Tineke J; Imholz, Alex; Blanken, Charlotte F J M; Siesling, Sabine; van Dalen, Thijs

Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer

乳腺癌患者化疗期间的饮食摄入量与非癌症女性的饮食摄入量存在差异

de Vries, Y C; van den Berg, M M G A; de Vries, J H M; Boesveldt, S; de Kruif, J Th C M; Buist, N; Haringhuizen, A; Los, M; Sommeijer, D W; Timmer-Bonte, J H N; van Laarhoven, H W M; Visser, M; Kampman, E; Winkels, R M

The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours

(18)F-FDG PET在鉴别肺转移瘤和同步性第二原发性肺肿瘤中的作用

Dijkman, Bernadette G; Schuurbiers, Olga C J; Vriens, Dennis; Looijen-Salamon, Monika; Bussink, Johan; Timmer-Bonte, Johanna N H; Snoeren, Miranda M; Oyen, Wim J G; van der Heijden, Henricus F M; de Geus-Oei, Lioe-Fee